This patient experienced long-lasting improvement of psoriasis that was previously refractory to biologics, suggesting that severe, resistant lesions may benefit from GLP-1 agonist therapy
Materials and Methods: A systematic search of PubMed, Embase, and Scopus till August 2024 identified randomized controlled trials (RCTs) reporting GI cancer outcomes
While GLP-1 agonists address only one component of this dual deficit, tirzepatide's simultaneous targeting of both pathways represents a more physiologically complete intervention
Reheat portions throughout the week for quick dinners
(2026 Guide) Decision framework for choosing the best GLP-1 drug: by max weight loss, CV protection, oral option, diabetes control, or liver fat